莆田招聘

收简历邮箱 ta_northchina@pfizer.com

JOB SUMMARY

The Regulatory Policy Lead is responsible for collecting, disseminating, archiving and analyzing a wide range of regulatory intelligence important to the Pfizer regulatory business.

This role facilitates the creation of Pfizer’s position on critical regulatory policy issues and promotes alignment within Pfizer. The RPL also assumes the responsibility for creating targeted advocacy plans and directly advocate through trade and professional associations and with relevant regulators.

The roles also be responsible for the training of the entire WRS China team

The RPL will work closely with regulatory policy officers, overseeing their work and providing training and mentor role.

KEY RESULT AREAS & JOB ACTIVITIES /TASKS

• Develop close internal working relationships with China regulatory project team, WRS-EM, Regional Medical, Legal, P&P, and other primary stakeholders to prioritize regulatory advocating activities, and maximize business value.
• Link closely with regulatory project team and other stakeholders to identify and disseminate regulatory intelligence and policy information to China leadership team, WRS Leadership, China Strategy, Med/Clinical Development, and other primary stakeholders
• Analyze significant regulatory policy issues and trends that effect Pfizer China regulatory business with immediate timeframe
• Facilitate the creation and dissemination of Pfizer’s regulatory policy position on critical topics, as needed.
• Build and maintain relationships with China health authority policy decision-makers in order to support Pfizer’s reputation as a collaborative partner and thought leader, and to positively impact regulatory policy advocacy.
• Actively involve and lead the regulatory advocacy activities initiated by RDPAC and other industry association
• Manage the RP officers ensure tasks and projects are completed effectively and efficiently
• Play key roles in the domestic and international industry association for regulatory advocacy activities
• Make presentation in industry or regulatory conference on behalf of Pfizer

EDUCATION & EXPERIENCE REQUIREMENTS

1, Educational /Training

BA/BS, Master degree with 5+ yrs of relevant experience, in one or more of the following; regulatory policy, regulatory affairs, management, government relations, and/or related fields.

2, Working Experiences

Minimum 8 years experience in government affairs or regulatory affairs or industry association or consult company working at a high level of competency.

Strong understanding of the China regulatory environment.

Deep knowledge of pharmaceutical research, development and commercialization.

Good at Presentation in English

Good working knowledge and experience for different therapeutic areas

Good working knowledge of international and local regulatory guidelines and codes

Proficiency in Basic Microsoft Word, PowerPoint and Excel and familiarity with use of databases

COMPETENCIES REQUIREMENTS

1. Ability Functional

Ability to advocate effectively in writing and in person

Effective influencing

Communication and interpersonal skill

Judgment/problem Assessment and problem solving skill

Teamwork and Collaboration

Negotiation skill

Project management

Quality Orientation

Technical and professional knowledge

2. Cultural Competencies (Leader Behaviors)

• Sustain Focus on Performance
• Create an Inclusive Environment
• Encourage Open Discussion and Debate
• Manage Change
• Develop People
• lAlign Across Pfizer

辉瑞公司（Pfizer Inc.）创建于1849年，迄今已有160多年的历史，总部位于美国纽约，是目前全球***的以研发为基础的生物制药公司。辉瑞致力于运用创新的科学技术以及全球资源来改善每个生命阶段的健康和福祉。
我们的目标是“不断创新为患者带来能显著改善其健康的药物”。我们的使命是“成为一家卓越的创新型生物制药公司”。
2012年辉瑞公司全年合计收入590亿美元，研发投入78亿美元。辉瑞在全球拥有9万多名员工，59家生产基地，业务遍及全球150多个国家和地区。2012年财富全球500强企业中辉瑞排名126位。
目前辉瑞公司的产品覆盖了包括化学药物、生物制剂、疫苗、健康药物、动物保健品等用于人类、动物和消费者保健等诸多广泛而极具潜力的治疗及健康领域，同时其卓越的研发和生产能力处于全球领先地位。
在人类和动物药品的发现、开发和生产过程中，辉瑞始终致力于奉行严格的质量、安全和价值标准。每天，分布在世界各地的辉瑞员工致力于促进当地医疗卫生的发展以及探索能够应对当今最为棘手疾病的预防和治疗方案。
辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
辉瑞生物制药目前在华上市的创新药物已超过50个，其治疗领域涵盖了心脑血管及代谢、抗感染、中枢神经、抗炎镇痛、抗肿瘤、泌尿、疫苗及等诸多领域。其中如立普妥®、络活喜®、万艾可®、舒普深®、希舒美®、沛儿®、索坦®许多产品在市场上处于领先地位。为了让中国的广大患者能及时接受与全球同步的先进的药物治疗，辉瑞未来将进一步加大和加快在华新药引进和上市的力度和速度。
辉瑞健康药物旗下的善存®、钙尔奇®、惠菲宁®等消费保健产品也在中国市场家喻户晓，并以其优异的品质深受广大消费者的青睐；辉瑞旗下的硕腾动物保健品*为中国的动物保健市场提供各类领先的动物疫苗和动物药品。

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products of healthcare industry and many of the world's best-known healthcare products such as Centrum. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 160 years, Pfizer has worked to make a difference for all who rely on us.